174 related articles for article (PubMed ID: 25772486)
21. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
22. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.
Pang B; Fan H; Zhang IY; Liu B; Feng B; Meng L; Zhang R; Sadeghi S; Guo H; Pang Q
J Neurooncol; 2012 Feb; 106(3):543-9. PubMed ID: 21984063
[TBL] [Abstract][Full Text] [Related]
23. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
[TBL] [Abstract][Full Text] [Related]
24. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.
Zhou WB; Zhong CN; Luo XP; Zhang YY; Zhang GY; Zhou DX; Liu LP
Biochem Biophys Res Commun; 2016 Feb; 470(4):838-44. PubMed ID: 26806308
[TBL] [Abstract][Full Text] [Related]
25. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Piscuoglio S; Zlobec I; Pallante P; Sepe R; Esposito F; Zimmermann A; Diamantis I; Terracciano L; Fusco A; Karamitopoulou E
Histopathology; 2012 Feb; 60(3):397-404. PubMed ID: 22276603
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
Di Cello F; Shin J; Harbom K; Brayton C
Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
Takahashi Y; Sawada G; Sato T; Kurashige J; Mima K; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Tanaka J; Kudo SE; Doki Y; Mori M; Mimori K
Oncol Rep; 2013 Sep; 30(3):1488-96. PubMed ID: 23835740
[TBL] [Abstract][Full Text] [Related]
30. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
32. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
33. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract][Full Text] [Related]
35. HMGA1 accelerates the malignant progression of gastric cancer through stimulating EMT.
Jin GH; Shi Y; Tian Y; Cao TT; Mao Y; Tang TY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3642-3647. PubMed ID: 32329839
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
[TBL] [Abstract][Full Text] [Related]
37. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
38. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.
Wei JJ; Wu X; Peng Y; Shi G; Basturk O; Yang X; Daniels G; Osman I; Ouyang J; Hernando E; Pellicer A; Rhim JS; Melamed J; Lee P
Clin Cancer Res; 2011 Mar; 17(6):1297-305. PubMed ID: 21138859
[TBL] [Abstract][Full Text] [Related]
39. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
[TBL] [Abstract][Full Text] [Related]
40. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
